Latest Brain tumor Stories
MADISON, Wis., Sept. 7, 2012 /PRNewswire/ -- Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that three clinical imaging posters based on research conducted by Lance Hall, M.D., Anne M. Traynor, M.D., Glenn Liu, M.D., Jamey Weichert, Ph.D. and their colleagues are being presented at the World Molecular Imaging Congress taking place September 5-8, 2012 in Dublin, Ireland. These...
VANCOUVER, British Columbia, Sept. 7, 2012 /PRNewswire/ -- Del Mar Pharmaceuticals today announced that Jeffrey A. Bacha, President & Chief Executive Officer, will present at the 14th Annual Rodman & Renshaw Healthcare Conference on September 11th at the Waldorf Astoria Hotel in New York City. Presentation Details Date: Tuesday, Sep 11, 2012 Time: 4.30 - 4.55 PM Location: Waldorf Astoria Hotel, Starlight South About DelMar PharmaDel Mar Pharmaceuticals was founded in...
Heartfelt documentary about a 10-year-old rescue dog with brain cancer nominated for two prestigious Emmy® Awards WASHINGTON, Sept. 5, 2012 /PRNewswire-USNewswire/ -- FBR Media announced today its television show "Dakota's Brain" is nominated for two 2012 Emmy® Awards in the documentary category of the National Academy of Television Arts and Sciences' Upper Midwest Chapter competition. "Dakota's Brain" is a 28-minute television show that chronicles the story of 10-year-old Dakota,...
CITY OF INDUSTRY, Calif., Sept. 5, 2012 /PRNewswire/ -- MASEP Infini, an innovator in global medical technology, and Centro Internacional de Cancer, located in San Salvador, El Salvador, Central America, today announced that the Center has acquired the Infini(TM) Gamma Ray Radiosurgery System for its Radiosurgery Center. With this acquisition, Centro Internacional de Cancer becomes the first center in Latin America to offer its patients the latest generation noninvasive treatment...
PARIS, Sept. 4, 2012 /PRNewswire/ -- Four advanced radiotherapy treatment systems from Varian Medical Systems (NYSE: VAR) have been ordered by Institut Curie, one of Europe's foremost comprehensive cancer centers, to replace older and less capable machines. Institut Curie, which operates at three sites in Paris, is acquiring three Varian TrueBeam(TM) systems and a Novalis Tx(TM) machine to extend the range of modern cancer treatments offered to patients. The largest hospital in...
This discovery can potentially prevent the progression and relapse of deadly brain tumoursSingapore, Sept 4, 2012 - (ACN Newswire) - A*STAR scientists have identified a biomarker of the most lethal form of brain tumours in adults - glioblastoma multiforme(1). The scientists found that by targeting this biomarker and depleting it with a potential drug, they were able to prevent the progression and relapse of the brain tumour.This research was conducted by scientists at...
Opportunities Available for Cross-Disciplinary Fields Chicago, IL (PRWEB) August 29, 2012 The American Brain Tumor Association (ABTA) is now accepting Letters of Intent for its Discovery Grant funding program. Letters are due in the ABTA office no later than 11:59 p.m. (CDT) on October 10, 2012. Discovery Grants are one-year, $50,000 grants that fund high-impact projects deemed to have the potential to change current diagnostic or treatment paradigms for adult and pediatric brain tumor...
U-M scientists stop abnormal brain cell growth in mice with neurofibromatosis using experimental tumor drug, make new discoveries in neural stem cells A drug originally developed to stop cancerous tumors may hold the potential to prevent abnormal brain cell growth and learning disabilities in some children, if they can be diagnosed early enough, a new animal study suggests. The surprising finding sets the stage for more research on how anti-tumor medication might be used to protect the...
DALLAS, Aug. 28, 2012 /PRNewswire/ -- The Beryl Companies will host the 5(th) Annual Barry Spiegelman Memorial Golf Classic October 1, 2012 at Timarron Country Club in Southlake, Texas. The tournament will celebrate the life of Beryl co-founder Barry Spiegelman and support brain cancer research at UCLA's Neuro-Oncology program, Art of the Brain. Spiegelman lost his battle with brain cancer in 2005. (Logo: http://photos.prnewswire.com/prnh/20120214/DA52846LOGO) Spiegelman...
MADISON, Wis., Aug. 28, 2012 /PRNewswire/ -- Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that it is developing CLR1502 (GLOW2), a preclinical cancer-targeted optical imaging agent for intraoperative tumor margin illumination and non-invasive tumor imaging. GLOW2 is expected to facilitate and enable diagnostic, staging, debulking and curative cancer surgeries intraoperatively in...
